These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36788180)

  • 41. Blood Pressure-Attained Analysis of ATACH 2 Trial.
    Qureshi AI; Palesch YY; Foster LD; Barsan WG; Goldstein JN; Hanley DF; Hsu CY; Moy CS; Qureshi MH; Silbergleit R; Suarez JI; Toyoda K; Yamamoto H;
    Stroke; 2018 Jun; 49(6):1412-1418. PubMed ID: 29789395
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Premorbid Blood Pressure Control Modifies Risk of DWI Lesions With Acute Blood Pressure Reduction in Intracerebral Hemorrhage.
    Ridha M; Hannawi Y; Murthy S; Carvalho Poyraz F; Kumar A; Park S; Roh D; Sekar P; Woo D; Burke J
    Hypertension; 2024 Oct; 81(10):2113-2123. PubMed ID: 39069917
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.
    Anderson CS; Heeley E; Huang Y; Wang J; Stapf C; Delcourt C; Lindley R; Robinson T; Lavados P; Neal B; Hata J; Arima H; Parsons M; Li Y; Wang J; Heritier S; Li Q; Woodward M; Simes RJ; Davis SM; Chalmers J;
    N Engl J Med; 2013 Jun; 368(25):2355-65. PubMed ID: 23713578
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.
    Mazighi M; Richard S; Lapergue B; Sibon I; Gory B; Berge J; Consoli A; Labreuche J; Olivot JM; Broderick J; Duhamel A; Touze E; Qureshi AI; Yavchitz A; Escalard S; Desilles JP; Redjem H; Smajda S; Fahed R; Hébert S; Maïer B; Delvoye F; Boursin P; Maacha MB; Obadia M; Sabben C; Blanc R; Savatovsky J; Piotin M;
    Lancet Neurol; 2021 Apr; 20(4):265-274. PubMed ID: 33647246
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of Clevidipine and Nicardipine for Acute Blood Pressure Reduction in Patients With Stroke.
    Allison TA; Bowman S; Gulbis B; Hartman H; Schepcoff S; Lee K
    J Intensive Care Med; 2019; 34(11-12):990-995. PubMed ID: 28820038
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Blood pressure and clinical outcomes in the International Stroke Trial.
    Leonardi-Bee J; Bath PM; Phillips SJ; Sandercock PA;
    Stroke; 2002 May; 33(5):1315-20. PubMed ID: 11988609
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Relation between change in blood pressure in acute stroke and risk of early adverse events and poor outcome.
    Sandset EC; Murray GD; Bath PM; Kjeldsen SE; Berge E;
    Stroke; 2012 Aug; 43(8):2108-14. PubMed ID: 22627991
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial.
    Anderson CS; Huang Y; Wang JG; Arima H; Neal B; Peng B; Heeley E; Skulina C; Parsons MW; Kim JS; Tao QL; Li YC; Jiang JD; Tai LW; Zhang JL; Xu E; Cheng Y; Heritier S; Morgenstern LB; Chalmers J;
    Lancet Neurol; 2008 May; 7(5):391-9. PubMed ID: 18396107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of the high admission blood pressure in mild-to-moderate acute intracerebral hemorrhage.
    Wang X; Sandset EC; Moullaali TJ; Chen G; Song L; Carcel C; Delcourt C; Woodward M; Robinson T; Chalmers J; Arima H; Anderson CS;
    J Hypertens; 2019 Jul; 37(7):1463-1466. PubMed ID: 31085948
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Off-Hour Admission and Outcomes in Patients with Acute Intracerebral Hemorrhage in the INTERACT2 Trial.
    Sato S; Arima H; Heeley E; Hirakawa Y; Delcourt C; Lindley RI; Robinson T; Huang Y; Morgenstern L; Stapf C; Wang J; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2015; 40(3-4):114-20. PubMed ID: 26202097
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial.
    Potter JF; Robinson TG; Ford GA; Mistri A; James M; Chernova J; Jagger C
    Lancet Neurol; 2009 Jan; 8(1):48-56. PubMed ID: 19058760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage.
    Moullaali TJ; Wang X; Martin RH; Shipes VB; Qureshi AI; Anderson CS; Palesch YY
    Int J Stroke; 2019 Apr; 14(3):321-328. PubMed ID: 30418098
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Target Blood Pressure in Patients with Diabetes: Asian Perspective.
    Park S; Kario K; Park CG; Huang QF; Cheng HM; Hoshide S; Wang JG; Chen CH;
    Yonsei Med J; 2016 Nov; 57(6):1307-11. PubMed ID: 27593856
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Individualized blood pressure targets in the postoperative care of patients with intracerebral hemorrhage.
    Lindner A; Rass V; Ianosi BA; Schiefecker AJ; Kofler M; Gaasch M; Addis A; Rhomberg P; Pfausler B; Beer R; Schmutzhard E; Thomé C; Helbok R
    J Neurosurg; 2021 Dec; 135(6):1656-1665. PubMed ID: 33836501
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
    Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
    JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Practice Patterns for Neurosurgical Utilization and Outcome in Acute Intracerebral Hemorrhage: Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trials 1 and 2 Studies.
    Guo R; Blacker DJ; Wang X; Arima H; Lavados PM; Lindley RI; Chalmers J; Anderson CS; Robinson T;
    Neurosurgery; 2017 Dec; 81(6):980-985. PubMed ID: 28605557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
    Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results.
    Wang X; Arima H; Yang J; Zhang S; Wu G; Woodward M; Muñoz-Venturelli P; Lavados PM; Stapf C; Robinson T; Heeley E; Delcourt C; Lindley RI; Parsons M; Chalmers J; Anderson CS;
    Stroke; 2015 Oct; 46(10):2762-7. PubMed ID: 26265125
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systolic blood pressure reduction in patients with intracranial hemorrhage and functional prognosis].
    Rodríguez-Herrera DA; Hernández-Plata AE; Hernández-González MA; Solorio-Meza SE
    Rev Med Inst Mex Seguro Soc; 2023 Sep; 61(Suppl 2):S200-S206. PubMed ID: 38011700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.